• Independence Day
  • About BreezyScroll
  • Privacy & Policy
  • Contact Us
Saturday, November 21, 2026
BreezyScroll
  • Home
  • Breezy Stories
  • Technology
  • Gaming
  • Entertainment
  • Lifestyle
  • World
  • Money
  • Sports
  • Breezy Explainer
  • Dussehra
No Result
View All Result
  • Home
  • Breezy Stories
  • Technology
  • Gaming
  • Entertainment
  • Lifestyle
  • World
  • Money
  • Sports
  • Breezy Explainer
  • Dussehra
No Result
View All Result
BreezyScroll
No Result
View All Result

Home  /  World  /  The US  /  FDA approves Eli Lilly drug for early Alzheimer’s treatment

FDA approves Eli Lilly drug for early Alzheimer’s treatment

by Siddhi Vinayak Misra
July 3, 2024
in Health, The US, World
Reading Time: 2 mins read
FDA approves Eli Lilly drug for early Alzheimer’s treatment

The US Food and Drug Administration (FDA) has approved a new drug developed by Eli Lilly designed to treat early symptoms of Alzheimer’s disease.

Treatment for early-stage Alzheimer’s

The drug, named Kisunla, is intended for “patients with mild cognitive impairment or mild dementia stage of disease,” according to the FDA’s statement. The FDA highlighted that “patients treated with Kisunla demonstrated a statistically significant reduction in clinical decline,” along with meeting a range of other criteria.

Kisunla, the brand name for donanemab-azbt, is among a limited number of drugs approved by the US regulator to address Alzheimer’s disease, which currently impacts over 6.5 million Americans.

ADVERTISEMENT

Promising results and early intervention

“Kisunla demonstrated very meaningful results for people with early symptomatic Alzheimer’s disease,” said Anne White, Eli Lilly’s executive vice president, in a statement from the pharmaceutical company. White emphasized the importance of early treatment, stating, “We know these medicines have the greatest potential benefit when people are treated earlier in their disease, and we are working hard in partnership with others to improve detection and diagnosis.”

Positive reception from the Alzheimer’s Association

The Alzheimer’s Association, a non-profit organization dedicated to eradicating the disease, welcomed the FDA’s decision. “This is real progress,” said Joanne Pike, the association’s president. “Today’s approval allows people more options and greater opportunity to have more time.” Pike underscored the importance of having multiple treatment options, calling it “the kind of advancement we’ve all been waiting for — all of us who have been touched, even blindsided, by this difficult and devastating disease.”

Tags: Alzheimer’s
ShareTweetShareSend
ADVERTISEMENT

Recent Articles

Older men and women with arms outstretched during an exercise class in a community hall

Higher BMI After 65 Tracked Lower Death Risk. Waist Didn’t

November 18, 2026
The Pitt Building, the Gothic-revival home of Cambridge University Press on Trumpington Street in Cambridge

Cambridge Dictionary’s 2026 Word of the Year Is ‘Human’

November 18, 2026
A limousine and a police car at the entrance of the Shenzhen International Exchange Center beside an APEC China 2026 sign

Shenzhen Offered One Household $1,500 to Leave During APEC

November 18, 2026
Two men stand in the plant-filled ground-floor lobby of Anthropic's San Francisco office, with wooden seating booths on either side

Anthropic Researcher Says AI Will Make Humans Unemployable

November 18, 2026
BreezyScroll Logo

BreezyScroll is a global content platform that provides a unique experience of enhancing the knowledge quotient for its audience by providing the latest news and updates from various categories such as politics, sports, entertainment, technology, and more.
The platform aims to provide a concise and easy-to-read format for its users. BreezyScroll covers news stories from around the world, majorly the United States. The platform was launched in 2021 and has become one of the fastest-growing content companies in the US.

Follow Us

Browse by Category

  • Africa
  • Alaska
  • Animals
  • Asia
  • Athletics
  • Australia
  • Auto
  • Basketball
  • Bollywood
  • Brand
  • Breezy Explainer
  • Breezy Feature
  • Breezy Soul
  • Business
  • Canada
  • Chess
  • China
  • Cricket
  • DIY
  • Education
  • Entertainment
  • Environment
  • EPL
  • Europe
  • Exclusive Interview
  • Exclusive Review
  • Football
  • Gaming
  • Health
  • Hollywood
  • India
  • International
  • K Pop
  • Law
  • Lifestyle
  • Middle East
  • Money
  • NFL
  • North America
  • OTT
  • Paris Olympics
  • Pets
  • Russia
  • Science
  • South America
  • Space
  • Sports
  • Startup
  • Technology
  • Tennis
  • Tennis
  • The Achievers
  • The US
  • Travel
  • UK
  • UK
  • Uncategorized
  • World
  • WWE

Trending Topics

AI Apple Artificial Intelligence Australia Biden California Canada ChatGPT China Climate Change Donald Trump Elon Musk FBI Featured Florida Google IPL Iran Japan Joe Biden Mars Meta Moon NASA NBA Netflix New York North Korea Ohio OpenAI Putin Russia Russia-Ukraine crisis South Korea SpaceX Taliban Tesla Texas TikTok Trump Twitter UFO UK Ukraine Virat Kohli

No Result
View All Result
  • About BreezyScroll
  • Breezy Stories
  • Contact Us
  • Corrections Policy
  • Editorial Policy and Standards
  • Masthead
  • Privacy Policy
  • World News – Latest News Today | BreezyScroll

© 2024 · BreezyScroll.com

No Result
View All Result
  • Home
  • Breezy Stories
  • Technology
  • Gaming
  • Entertainment
  • Lifestyle
  • World
  • Money
  • Sports
  • Breezy Explainer
  • Dussehra

© 2024 · BreezyScroll.com

Go to mobile version